Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#1812 Correlation of Plasma (p) and Urine (u) 5-HIAA Levels in Patients (pts) with Carcinoid Syndrome (CS) – Post-Hoc Analyses from the TELESTAR Study

Introduction: Telotristat ethyl (TE) is an oral tryptophan hydroxylase inhibitor in development for treating CS symptoms. During the double-blind treatment [DBT] period of the phase 3, 12-week, placebo-controlled TELESTAR study, TE was well tolerated and significantly reduced bowel-movement frequency and u5-HIAA levels compared with placebo (PBO) in NET patients with CS treated with a SSA.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Pavel M, Hörsch D, Hoffmanns P, Biran T, Houchard A,

Keywords: carcinoid syndrome, 5-HIAA, telotristat,

#1809 What Do We Know About Carcinoid Heart Disease? A Systematic Literature Review

Introduction: Carcinoid heart disease (CHD) is a life-threatening complication of carcinoid syndrome (CS).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Ovcinnikova O

Authors: Ovcinnikova O, Marshall M, Bagnati F, Hoffmanns P, Taveau ,

Keywords: carcinoid heart disease, systematic literature review, outcomes,

#1806 Epidemiology of Carcinoid Heart Disease (CHD) in Patients (pts) with Carcinoid Syndrome (CS): A Systematic Literature Review

Introduction: CHD develops in the context of CS due to the exposure of high levels of vasoactive substances, such as serotonin.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Ovcinnikova O

Authors: Ovcinnikova O, Marshall M, Bagnati F, Hoffmanns P, Taveau C,

Keywords: carcinoid syndrome, heart disease, epidemiology, prevalence, mortality,